Syndetics cover image
Image from Syndetics

The Evidence-Based Guide to Antipsychotic Medications [electronic resource].

By: Material type: Computer fileComputer filePublisher number: 9781585623662Publication details: Arlington : American Psychiatric Publishing, Inc., 2010.ISBN:
  • 9781585629299
Subject(s): Genre/Form: Additional physical formats: Print version:: The Evidence-Based Guide to Antipsychotic MedicationsDDC classification:
  • 615/.7882
LOC classification:
  • RM333.5 .E95 2010
Online resources:
Contents:
Cover; Contents; Contributors; Acknowledgments; Disclaimer; 1 Introduction; 2 Schizophrenia and Schizoaffective Disorder; TREATMENT GOALS; CLINICIAN-PATIENT RELATIONSHIP; ANTIPSYCHOTIC MEDICATIONS; TREATMENT OF SCHIZOPHRENIA; TREATMENT OF SCHIZOAFFECTIVE DISORDER; TREATMENT ADHERENCE; KEY CLINICAL POINTS; REFERENCES; 3 Mood and Anxiety Disorders; BIPOLAR DISORDER; KEY CLINICAL POINTS: BIPOLAR DISORDER; PSYCHOTIC DEPRESSION; KEY CLINICAL POINTS: PSYCHOTIC DEPRESSION; TREATMENT-RESISTANT DEPRESSION; KEY CLINICAL POINTS: TREATMENT-RESISTANT DEPRESSION; NONPSYCHOTIC DEPRESSION
Appendix 7 Side Effects of Commonly Used Antipsychotics
DISCONTINUING ANTIPSYCHOTIC TREATMENTKEY CLINICAL POINTS; REFERENCES; 7 Use of Antipsychotics in Geriatric Patients; GENERAL PRINCIPLES OF MEDICATION MANAGEMENT; AGE-SPECIFIC ISSUES RELATED TO SIDE EFFECTS; RISKS UNIQUE TO PATIENTS WITH DEMENTIA; USE OF ANTIPSYCHOTIC MEDICATIONS IN LONG-TERM-CARE FACILITIES; MEDICATION MANAGEMENT FOR PATIENTS WITH PSYCHIATRIC AND NEUROPSYCHIATRIC DISORDERS; KEY CLINICAL POINTS; REFERENCES; 8 Use of Antipsychotics in Medically Ill Patients; MEDICAL CONSIDERATIONS IN THE USE OF ANTIPSYCHOTICS; GENERAL CONDITIONS; MEDICAL DISORDERS; KEY CLINICAL POINTS
KEY CLINICAL POINTS: NONPSYCHOTIC DEPRESSIONOBSESSIVE-COMPULSIVE DISORDER; KEY CLINICAL POINTS: OBSESSIVE-COMPULSIVE DISORDER; GENERALIZED ANXIETY DISORDER; KEY CLINICAL POINTS: GENERALIZED ANXIETY DISORDER; POSTTRAUMATIC STRESS DISORDER; KEY CLINICAL POINTS: POSTTRAUMATIC STRESS DISORDER; SAFETY AND TOLERABILITY OF ANTIPSYCHOTICS IN MOOD AND ANXIETY DISORDERS: FUNDAMENTAL CONCEPTS; REFERENCES; 4 Personality Disorders; HOW PSYCHOSIS IS VIEWED IN PERSONALITY DISORDER; HISTORICAL CONSIDERATIONS; MECHANISM OF ACTION; INDICATIONS AND EFFICACY; CLINICAL USE; GUIDELINES FOR SELECTION AND USE
REFERENCESAppendix 1 Names, Strengths, and Formulations of First- and Second-Generation Antipsychotics; Appendix 2 Pharmacokinetics of First- and Second-Generation Antipsychotics; Appendix 3 Dosing and Administration of First- and Second-Generation Antipsychotics in Schizophrenia; Appendix 4 Medical Workup When Initiating and Continuing First- and Second-Generation Antipsychotics; Appendix 5 Medical Workup When Initiating and Continuing Clozapine; Appendix 6 Use of First- and Second-Generation Antipsychotics for Agitation Due to Psychosis
SIDE EFFECTS AND THEIR MANAGEMENTBORDERLINE PERSONALITY DISORDER; SCHIZOTYPAL PERSONALITY DISORDER; OTHER PERSONALITY DISORDERS; KEY CLINICAL POINTS; REFERENCES; 5 Substance Abuse Disorders; SUBSTANCE-RELATED PSYCHOMOTOR AGITATION; SUBSTANCE-ASSOCIATED PSYCHOTIC SYMPTOMS AND DISORDERS; CO-OCCURRING DISORDERS; SUBSTANCE USE DISORDERS; KEY CLINICAL POINTS; REFERENCES; 6 Use of Antipsychotics in Children and Adolescents; INDICATIONS AND EFFICACY; SECOND-GENERATION ANTIPSYCHOTICS; FIRST-GENERATION ANTIPSYCHOTICS; ANTIPSYCHOTIC TREATMENT OF PEDIATRIC PSYCHIATRIC DISORDERS
Summary: The Evidence-Based Guide to Antipsychotic Medications is a table-rich, comprehensive overview of our current knowledge regarding the use of antipsychotic medications to treat a broad range of psychiatric conditions, from anxiety disorders to schizophrenia.
Holdings
Item type Home library Call number Status Date due Barcode Item holds
Electronic Resource Electronic Resource UH Online Library Ebooks Not for loan
Total holds: 0

Enhanced descriptions from Syndetics:

Description based upon print version of record.

Cover; Contents; Contributors; Acknowledgments; Disclaimer; 1 Introduction; 2 Schizophrenia and Schizoaffective Disorder; TREATMENT GOALS; CLINICIAN-PATIENT RELATIONSHIP; ANTIPSYCHOTIC MEDICATIONS; TREATMENT OF SCHIZOPHRENIA; TREATMENT OF SCHIZOAFFECTIVE DISORDER; TREATMENT ADHERENCE; KEY CLINICAL POINTS; REFERENCES; 3 Mood and Anxiety Disorders; BIPOLAR DISORDER; KEY CLINICAL POINTS: BIPOLAR DISORDER; PSYCHOTIC DEPRESSION; KEY CLINICAL POINTS: PSYCHOTIC DEPRESSION; TREATMENT-RESISTANT DEPRESSION; KEY CLINICAL POINTS: TREATMENT-RESISTANT DEPRESSION; NONPSYCHOTIC DEPRESSION

Appendix 7 Side Effects of Commonly Used Antipsychotics

DISCONTINUING ANTIPSYCHOTIC TREATMENTKEY CLINICAL POINTS; REFERENCES; 7 Use of Antipsychotics in Geriatric Patients; GENERAL PRINCIPLES OF MEDICATION MANAGEMENT; AGE-SPECIFIC ISSUES RELATED TO SIDE EFFECTS; RISKS UNIQUE TO PATIENTS WITH DEMENTIA; USE OF ANTIPSYCHOTIC MEDICATIONS IN LONG-TERM-CARE FACILITIES; MEDICATION MANAGEMENT FOR PATIENTS WITH PSYCHIATRIC AND NEUROPSYCHIATRIC DISORDERS; KEY CLINICAL POINTS; REFERENCES; 8 Use of Antipsychotics in Medically Ill Patients; MEDICAL CONSIDERATIONS IN THE USE OF ANTIPSYCHOTICS; GENERAL CONDITIONS; MEDICAL DISORDERS; KEY CLINICAL POINTS

KEY CLINICAL POINTS: NONPSYCHOTIC DEPRESSIONOBSESSIVE-COMPULSIVE DISORDER; KEY CLINICAL POINTS: OBSESSIVE-COMPULSIVE DISORDER; GENERALIZED ANXIETY DISORDER; KEY CLINICAL POINTS: GENERALIZED ANXIETY DISORDER; POSTTRAUMATIC STRESS DISORDER; KEY CLINICAL POINTS: POSTTRAUMATIC STRESS DISORDER; SAFETY AND TOLERABILITY OF ANTIPSYCHOTICS IN MOOD AND ANXIETY DISORDERS: FUNDAMENTAL CONCEPTS; REFERENCES; 4 Personality Disorders; HOW PSYCHOSIS IS VIEWED IN PERSONALITY DISORDER; HISTORICAL CONSIDERATIONS; MECHANISM OF ACTION; INDICATIONS AND EFFICACY; CLINICAL USE; GUIDELINES FOR SELECTION AND USE

REFERENCESAppendix 1 Names, Strengths, and Formulations of First- and Second-Generation Antipsychotics; Appendix 2 Pharmacokinetics of First- and Second-Generation Antipsychotics; Appendix 3 Dosing and Administration of First- and Second-Generation Antipsychotics in Schizophrenia; Appendix 4 Medical Workup When Initiating and Continuing First- and Second-Generation Antipsychotics; Appendix 5 Medical Workup When Initiating and Continuing Clozapine; Appendix 6 Use of First- and Second-Generation Antipsychotics for Agitation Due to Psychosis

SIDE EFFECTS AND THEIR MANAGEMENTBORDERLINE PERSONALITY DISORDER; SCHIZOTYPAL PERSONALITY DISORDER; OTHER PERSONALITY DISORDERS; KEY CLINICAL POINTS; REFERENCES; 5 Substance Abuse Disorders; SUBSTANCE-RELATED PSYCHOMOTOR AGITATION; SUBSTANCE-ASSOCIATED PSYCHOTIC SYMPTOMS AND DISORDERS; CO-OCCURRING DISORDERS; SUBSTANCE USE DISORDERS; KEY CLINICAL POINTS; REFERENCES; 6 Use of Antipsychotics in Children and Adolescents; INDICATIONS AND EFFICACY; SECOND-GENERATION ANTIPSYCHOTICS; FIRST-GENERATION ANTIPSYCHOTICS; ANTIPSYCHOTIC TREATMENT OF PEDIATRIC PSYCHIATRIC DISORDERS

The Evidence-Based Guide to Antipsychotic Medications is a table-rich, comprehensive overview of our current knowledge regarding the use of antipsychotic medications to treat a broad range of psychiatric conditions, from anxiety disorders to schizophrenia.